Dare Bioscience, Inc. — Director's Dealing 2015

Feb 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-02-05

Reporting Person: Roberts Karen Lynn (Sr VP Finance & Administrat)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-05	Stock Option (right to buy)	$8.16	A	43000	Acquired	2025-02-04	Common Stock (43000)	Direct

Footnotes

F1: This option was granted on February 5, 2015. The option vests as to 2.08333% of the underlying shares monthly through and including February 5, 2019.